等待开盘 08-12 09:30:00 美东时间
-0.060
-0.21%
The proportion of U.S. employers offering coverage for GLP-1 drugs for both diabetes and weight loss has sharply increased over the past six months amid new FDA approvals, a new survey conducted by th...
2024-06-14 20:01